Literature DB >> 15946251

Multivalent recombinant proteins for probing functions of leucocyte surface proteins such as the CD200 receptor.

Despina Voulgaraki1, Rita Mitnacht-Kraus, Michelle Letarte, Mildred Foster-Cuevas, Marion H Brown, A Neil Barclay.   

Abstract

CD200 (OX2) is a membrane glycoprotein that interacts with a structurally related receptor (CD200R) involved in the regulation of macrophage function. The interaction is of low affinity (K(D) approximately 1 microm) but can be detected using CD200 displayed in a multivalent form on beads or with dimeric fusion proteins consisting of the extracellular region of CD200 and immunoglobulin Fc regions. We prepared putative pentamers and trimers of mouse CD200 with sequences from cartilage oligomeric matrix protein (COMP) and surfactant protein D (SP-D), respectively. The COMP protein gave high-avidity binding and was a valuable tool for showing the interaction whilst the SP-D protein gave weak binding. In vivo experiments showed that an agonistic CD200R monoclonal antibody caused some amelioration in a model of experimental autoimmune encephalomyelitis but the COMP protein was cleared rapidly and had minimal effect. Pentameric constructs also allowed detection of the rat CD48/CD2 interaction, which is of much lower affinity (K(D) approximately 70 microm). These reagents may have an advantage over Fc-bearing hybrid molecules for probing cell surface proteins without side-effects due to the Fc regions. The CD200-COMP gave strong signals in protein microarrays, suggesting that such reagents may be valuable in high throughput detection of weak interactions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15946251      PMCID: PMC1782167          DOI: 10.1111/j.1365-2567.2005.02161.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  36 in total

1.  A recombinant homotrimer, composed of the alpha helical neck region of human surfactant protein D and C1q B chain globular domain, is an inhibitor of the classical complement pathway.

Authors:  U Kishore; P Strong; M V Perdikoulis; K B Reid
Journal:  J Immunol       Date:  2001-01-01       Impact factor: 5.422

2.  Putting the brakes on innate immunity: a regulatory role for CD200?

Authors:  C Nathan; W A Muller
Journal:  Nat Immunol       Date:  2001-01       Impact factor: 25.606

3.  Human herpesvirus 8 K14 protein mimics CD200 in down-regulating macrophage activation through CD200 receptor.

Authors:  Mildred Foster-Cuevas; Gavin J Wright; Michael J Puklavec; Marion H Brown; A Neil Barclay
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

4.  Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo.

Authors:  S P Cobbold; A Jayasuriya; A Nash; T D Prospero; H Waldmann
Journal:  Nature       Date:  1984 Dec 6-12       Impact factor: 49.962

5.  CD200 immunoadhesin suppresses collagen-induced arthritis in mice.

Authors:  R M Gorczynski; Z Chen; K Yu; J Hu
Journal:  Clin Immunol       Date:  2001-12       Impact factor: 3.969

6.  Analysis of the oligomeric requirement for signaling by CD40 using soluble multimeric forms of its ligand, CD154.

Authors:  L E Haswell; M J Glennie; A Al-Shamkhani
Journal:  Eur J Immunol       Date:  2001-10       Impact factor: 5.532

7.  Catabolism of homologous murine monoclonal hybridoma IgG antibodies in mice.

Authors:  P J Talbot; M J Buchmeier
Journal:  Immunology       Date:  1987-04       Impact factor: 7.397

Review 8.  CD200 and membrane protein interactions in the control of myeloid cells.

Authors:  A Neil Barclay; Gavin J Wright; Gary Brooke; Marion H Brown
Journal:  Trends Immunol       Date:  2002-06       Impact factor: 16.687

9.  Characterization of the CD200 receptor family in mice and humans and their interactions with CD200.

Authors:  Gavin J Wright; Holly Cherwinski; Mildred Foster-Cuevas; Gary Brooke; Michael J Puklavec; Mike Bigler; Yaoli Song; Maria Jenmalm; Dan Gorman; Terri McClanahan; Man-Ru Liu; Marion H Brown; Jonathon D Sedgwick; Joseph H Phillips; A Neil Barclay
Journal:  J Immunol       Date:  2003-09-15       Impact factor: 5.422

10.  A novel form of the membrane protein CD147 that contains an extra Ig-like domain and interacts homophilically.

Authors:  S Melanie Hanna; Peter Kirk; Oliver J Holt; Michael J Puklavec; Marion H Brown; A Neil Barclay
Journal:  BMC Biochem       Date:  2003-11-07       Impact factor: 4.059

View more
  19 in total

1.  Downstream of tyrosine kinase 1 and 2 play opposing roles in CD200 receptor signaling.

Authors:  Robin Mihrshahi; Marion H Brown
Journal:  J Immunol       Date:  2010-11-15       Impact factor: 5.422

2.  Large-scale screening for novel low-affinity extracellular protein interactions.

Authors:  K Mark Bushell; Christian Söllner; Benjamin Schuster-Boeckler; Alex Bateman; Gavin J Wright
Journal:  Genome Res       Date:  2008-02-22       Impact factor: 9.043

3.  Identification of leucocyte surface protein interactions by high-throughput screening with multivalent reagents.

Authors:  Lei Jiang; A Neil Barclay
Journal:  Immunology       Date:  2010-01       Impact factor: 7.397

Review 4.  Autoimmune therapies targeting costimulation and emerging trends in multivalent therapeutics.

Authors:  Chuda Chittasupho; Teruna J Siahaan; Charlotte M Vines; Cory Berkland
Journal:  Ther Deliv       Date:  2011-07

Review 5.  Signal initiation in biological systems: the properties and detection of transient extracellular protein interactions.

Authors:  Gavin J Wright
Journal:  Mol Biosyst       Date:  2009-12

6.  New assay to detect low-affinity interactions and characterization of leukocyte receptors for collagen including leukocyte-associated Ig-like receptor-1 (LAIR-1).

Authors:  Lei Jiang; A Neil Barclay
Journal:  Eur J Immunol       Date:  2009-04       Impact factor: 5.532

7.  Essential roles for Dok2 and RasGAP in CD200 receptor-mediated regulation of human myeloid cells.

Authors:  Robin Mihrshahi; A Neil Barclay; Marion H Brown
Journal:  J Immunol       Date:  2009-09-28       Impact factor: 5.422

8.  Synthesis and evaluation of multivalent M2pep peptides for targeting alternatively activated M2 macrophages.

Authors:  Chayanon Ngambenjawong; Maryelise Cieslewicz; Joan G Schellinger; Suzie H Pun
Journal:  J Control Release       Date:  2016-01-07       Impact factor: 9.776

9.  An extracellular interactome of immunoglobulin and LRR proteins reveals receptor-ligand networks.

Authors:  Engin Özkan; Robert A Carrillo; Catharine L Eastman; Richard Weiszmann; Deepa Waghray; Karl G Johnson; Kai Zinn; Susan E Celniker; K Christopher Garcia
Journal:  Cell       Date:  2013-07-03       Impact factor: 41.582

10.  Avidity-based extracellular interaction screening (AVEXIS) for the scalable detection of low-affinity extracellular receptor-ligand interactions.

Authors:  Jason S Kerr; Gavin J Wright
Journal:  J Vis Exp       Date:  2012-03-05       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.